Drug – bio-affecting and body treating compositions – Topical sun or radiation screening – or tanning preparations
Reexamination Certificate
2000-08-17
2001-10-23
Dodson, Shelley A. (Department: 1616)
Drug, bio-affecting and body treating compositions
Topical sun or radiation screening, or tanning preparations
C424S060000, C424S400000, C424S401000
Reexamination Certificate
active
06306373
ABSTRACT:
FIELD OF THE INVENTION
The present invention is directed to a high active sunscreen composition for topical application to human skin to protect the skin against UV radiation damage. The composition is particularly suitable for over-coating with make-up or other cosmetic compositions. More particularly, the present invention is directed to the use of a lower alkyl phthalamide that is surprisingly effective in solubilizing 4-(1,1-dimethylethyl)-4′-methoxydibenzoylmethane (PARSOL.RTM.1789). Such concentrates solutions of PARSOL.RTM. 1789 can be used to formulate a more effective sunscreen, having a surprisingly increased sunscreen protection factor (SPF) and such that the PARSOL.RTM. 1789 is more effective over a longer period of time so that the sunscreen composition need not be applied to the skin as frequently.
DESCRIPTIONS OF THE ARTS AND PRACTICES
It is well known that ultraviolet light having a wavelength between about 280 nm or 290 nm and 320 nm (UV-B) is harmful to human skin, causing burns that are detrimental to the development of a good sun tan. UV-A radiation, while producing tanning of the skin, also can cause damage, particularly to very lightly color, sensitive skin, leading to reduction of skin elasticity and wrinkles.
Therefore, a sunscreen composition should include both UV-A and UV-B filters to prevent most of the sunlight within the full range of about 280 nm to about 400 nm from damaging human skin.
The UV-B filters that are most widely used commercially in sunscreen compositions are paramethoxycinnamic acid esters, such as 2-ethylhexyl paramethoxycinnamate, commonly referred to as octyl methoxycinnamate or ARSOL.RTM. MCX, having an ethyl radical extending from the 2 position of the hexyl long chain backbone; and octyl salicylate.
A very desirable UV-A filter is 4-(1,1-dimethylethyl)-4′-methoxydibenzoylmethane (sold commercially as PARSOL.RTM. 1789). Sunscreens are commonly used as emulsions, that is a water phase into which is dispersed the sunscreen active in a suitable oil phase. It is also well known that is 4-(1,1-dimethylethyl)-4′-methoxydibenzoylmethane suffers from insolubility in a variety of solvents, commonly esters, requiring the use of large amounts of ester and a large concentration of oil phase in the sunscreen. The presence of the ester does not contribute to sunscreen efficiency, is costly and changes the skin feel of the emulsion applied to the skin. Additionally, the presence of the large concentration of ester results in several formulating problems for the chemist making sunscreens. One of these problems is that the ester used can result in a large organic loading of the emulsion and require large amounts of preservatives to keep bacteria from attacking the ester present as a solvent. The best solution would to develop a formulation in which the oil phase has a high concentration of 4-(1,1-dimethylethyl)-4′-methoxydibenzoylmethane and a low concentration of solvent. Before the present invention, the amount of 4-(1,1-dimethylethyl)-4′-methoxydibenzoylmethane that could be solubilized was quite limited. The use of the lower alkyl phthalamide compounds as sunscreen solubilizers address this very problem, a long felt need in the sunscreen market.
In accordance with the principles of the present invention, it has been found, quite surprisingly, that by using very specific ranges of mixed n-butyl and iso-propyl phthalamide compounds of the present invention, very high concentrations of UV-A dibenzyolmethane derivative, particularly PARSOL.RTM. 1789, or EUSOLEX 8020, the dibenzyolmethane derivative is solubilized resulting heretofore unattainable emulsions.
SUMMARY OF THE INVENTION
In brief, the present invention is directed to sunscreen compositions made up of a solution of 40% to 70% by weight of 4-(1,1-dimethylethyl)-4′-methoxydibenzoylmethane (PARSOL.RTM. 1789), and 30% to 60% by weight of a mixture of n-butyl, isopropyl phthalamide compound conforming to the following structure;
wherein;
R is a eutectic mixture having 60-75% by weight of CH
3
—(CH
2
)
3
— and 25%-40% by weight
The material is a mixture of the above alkyl groups. By making the specified mixtures of the alkyl groups, most importantly normal butyl and isopropyl, a so-called eutectic mixture results. This mixture is a liquid having a very low melting point and remains liquid over a wide range of temperatures. We have found that the increased solubilization of the sunscreen compounds in the mixture occurs only within the so-called eutectic range. Within the eutectic rang, a mixture of the compounds has a lower melting point than either of the two pure components in the mixture. We have discovered that this phenomenon is critically important in developing compounds that can solubilize high levels of sunscreening agents.
Surprisingly, the key to solubilizing large quantities of sunscreen is the selection of the aromatic, amid functional lower alkyl compounds. The industry has long recognized the need for efficient solubilizers, but has looked at esters. The ester class of compounds provides only minimal solubility, making their use difficult. The art as a whole taught away from the use of compounds other than esters and certainly did not anticipate the properties of the specific aromatic cyclic amides of the present invention. U.S. Pat. Nos. 5,783,173, 5,788,954, and 5,849,273 incorporated herein by reference teach that the optimum solubility of the specific sunscreens (avobenzone) in esters is 13% by weight at best. This means the oil phase must be present at a concentration of 87% by weight. As will become clear the compounds of the present invention will allow for the solubilization of 40% avobenzone by weight.
The above and other aspects and advantages of the present invention will become more apparent from the following detailed description of the preferred embodiments.
Preferred Embodiment
In a preferred embodiment R is 60% by weight CH
3
—(CH
2
)
3
— and 40% by weight
In a preferred embodiment R is 62% by weight CH
3
—(CH
2
)
3
— and 38% by weight
In a preferred embodiment R is 65% by weight CH
3
—(CH
2
)
3
— and 35% by weight
In a preferred embodiment R is 67% by weight CH
3
—(CH
2
)
3
— and 33% by weight
In a preferred embodiment R is 70% by weight CH
3
—(CH
2
)
3
— and 30% by weight
In a preferred embodiment R is 72% by weight CH
3
—(CH
2
)
3
— and 28% by weight
In a preferred embodiment R is 75% by weight CH
3
—(CH
2
)
3
— and 25% by weight
REFERENCES:
patent: 5204090 (1993-04-01), Sie-ta
Impernate John
O'Lenick, Jr. Anthony J.
Dodson Shelley A.
Phoenix Research Corporation
LandOfFree
Mixed n-butyl and iso-propyl phthalamide compounds as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mixed n-butyl and iso-propyl phthalamide compounds as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mixed n-butyl and iso-propyl phthalamide compounds as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2593917